Form 4: ResMed Director Sells Shares Under 10b5-1 Plan

ResMed Director Peter C. Farrell sold 2,000 shares of common stock for $251.47 per share under a pre-arranged 10b5-1 plan.

Summary

• Peter C. Farrell, a Director of ResMed Inc. (RMD), disposed of 2,000 shares of common stock.
• The transaction occurred on December 3, 2025, at a price of $251.47 per share.
• The sale was executed pursuant to a Rule 10b5-1 plan, which was adopted on August 12, 2025.
• Following this transaction, Peter C. Farrell directly beneficially owns 68,773 shares of ResMed Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a pre-scheduled sale under a Rule 10b5-1 plan, which typically indicates a neutral sentiment as it is often for personal financial planning rather than a reaction to new company information.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction report is specific to an individual director's stock activity and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: A director's sale, especially under a 10b5-1 plan, is generally not considered a significant indicator of future company performance and is unlikely to have a material impact on shareholder sentiment or the stock price.

Key Dates

Keywords

ResMed, RMD, Peter Farrell, Director, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction